Influence of menopause on biochemical markers of endothelial dysfunction-A case-control pilot study in North Indian population

Maturitas

Volumn 62, Issue 2, 2009, Pages 166-170

  Salhotra, Sangeeta ^a   Arora, Sarika ^b   Anubhuti, ^b   Trivedi, Sagar S ^a   Bhattacharjee, Jayashree ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Apolipoprotein B; c GMP; Estradiol; Lipid profile; Menopause; Nitric oxide

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; CYCLIC GMP; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; POPULATION; POSTMENOPAUSE; PREMENOPAUSE; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; INDIA; LIPID METABOLISM; LIPIDS; MENOPAUSE; MIDDLE AGED; NITRIC OXIDE; VASODILATION;

EID: 61349191552     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.11.024     Document Type: Article

References (44)

1. Blumel J.E., Curz M.N., and Aparicio N.J. Menopausal transition, pathophysiology, clinical and treatment. Medicina (B Aires) 62 (2002) 52-65
2. Kriplani A., and Bannerjee K. An overview of age of onset of menopause in northern India. Maturitas 52 3-4 (2005) 199-204
3. Amant C., Holm P., Xu S., Tritman N., Kearney M., and Losordo D.W. Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium; regulation of Fas ligand expression by estradiol. Circulation 104 (2001) 2576-2581
4. Pines A., Kessel H., Mijatovic V., and van der Mooren M.J. Hormone replacement therapy and cardioprotection in the elderly. J R Soc Med 91 9 (1998) 475-478
5. Gaugler M.H. A unifying system: does the vascular endothelium have a role to play in multi-organ failure following radiation exposure?. Br J Radiol 78 27 (2005) 100-105
6. Cornwell T.L., Arnold E., Boerth N.J., and Lincoln T.M. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP dependent protein kinase by cGMP. Am J Physiol Cell Physiol 36 (1994) 1405-1413
7. Mehta J.L., Mehta P., and Li D. Nitric oxide synthase in adult red blood cells: vestige of an earlier age or a biologically active enzyme?. J Lab Clin Med 135 (2000) 430-431
8. Tsuchiya K., Kanematsu Y., Yoshizumi M., et al. Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 288 5 (2005) H2163-H2170
9. Thompson L.P., Pinkas G., and Weiner C.P. Chronic 17β-estradiol replacement increases nitric oxide-mediated vasodilation of guinea pig coronary microcirculation. Circulation 102 (2000) 445-451
10. Guetta V., Quyyumi A.A., Prasad A., Panza J.A., Waclawiw M., and Cannon III R. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 96 (1997) 2795-2801
11. Arora S., Jain A., and Chitra R. Effects of short-term hormone replacement therapy on atherogenic indices in Indian postmenopausal women. IJCB 21 1 (2006) 41-47
12. Westerveld H.T., Roeters van Lennep J.E., Roeters van Lennep H.W.O., et al. Apolipoprotein B and coronary artery disease in women-a cross-sectional study in women undergoing their first coronary angiography. Arterioscler Thromb Vasc Biol 18 (1998) 1101-1107
13. Feron O., Dessy C., Moniotte S., Desager J.P., and Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103 6 (1999) 897-905
14. Santos R.L., Abreu G.R., Bissolli N.S., and Moyse{hook above}s M.R. Endothelial mediators of 17β-estradiol-induced coronary vasodilation in the isolated rat heart. Braz J Med Biol Res 37 (2004) 569-575
15. Rahimian R., Breemen C.V., Karkan D., Dube G., and Laher I. Estrogen augments cyclopiazonic acid-mediated, endothelium-dependent vasodilation. Eur J Pharmacol 327 2-3 (1997) 143-149
16. Sengupta A. The emergence of menopause in India. Climacteric 6 2 (2003) 92-95
17. Mathew G., Glenda J., and Jack L. Quantitation of nitrite and nitrate in extra-cellular fluids. Method Enzymol 268 (1996) 237-246
18. Komura H., Bukoski R.D., Karanja N., Morris C.D., Shingu T., and McCarron D.A. Effect of prostacyclin on platelet intracellular free calcium concentration of hypertensive and normotensive humans. Am J Hypertens 6 (1993) 730-735
19. Jabri J.E. Enzyme immunoassay for plasma estradiol using a monoclonal antibody. J Steroid Biochem Mol Biol 38 3 (1991) 339-343
20. Jacobs N.J., and Van Denmark P.J. The purification and properties of the alpha-glycerophosphate-oxidizing enzyme of Streptococcus faecalis 10 C1. Arch Biochem Biophys 88 (1960) 250-255
21. Friedwald T., Levy J., and Fredrickson S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-509
22. Mittal C.K. Oxygen radical/NO mediated calcium dependent hormone action on cGMP system: a novel concept in signal transduction mechanism. Mol Cell Biochem 149-150 (1995) 257-262
23. Butterworth R.J., Cluckie A., Jackson S.H.D., Thomas M.B., and Bath P.M.W. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 8 (1998) 158-165 10.1159/000015842
24. Hodgin J.B., Knowles J.W., Kim H.S., Smithies O., and Maeda N. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 109 (2002) 541-548
25. Hayashi T., Yamada K., Esaki T., Mutoh E., and Iguchi A. Effect of estrogen on isoforms of nitric oxide synthase. Possible mechanisms of anti-atherosclerotic effects of estrogen. Gerontology 43 (1997) 24-34
26. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the non-genomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406 10.1172/JCI5347
27. Schray-Utz B., Zeiher A.M., and Busse R. Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17β-estradiol. Circulation 88 Suppl. I (1993) I-80
28. 2+ mobilization. Circ Res 81 (1997) 885-892
29. i. J. Biol. Chem. 276 29 (2001) 27071-27076
30. Rosselli M., Imthurn B., Keller P.J., Jackson E.K., and Dubey R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 25 (1995) 848-853
31. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
32. Lobo R.A. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 73 (1991) 925-930
33. Emre A., Sahin S., Erzik C., et al. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-α IVS1-397 C/C genotype and established coronary artery disease. Cardiology 106 (2006) 44-50 10.1159/000092598
34. Levine G.N., Keaney J.F., and Vita J.A. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 332 (1995) 512-521
35. Wataru T., Ken-Ichiro T., Shinji T., et al. Low direct cytotoxicity and cytoprotective effects of nitric oxide releasing indomethacin. Dig Dis Sci 50 10 (2005) 1927-1937 10.1007/s10620-005-2963-4
36. Senöz S., Direm B., Gülekli B., and Gökmen O. Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women. Maturitas 25 2 (1996) 107-114
37. In: Mackay J., and Menash G. (Eds). The atlas of heart disease and stroke (2004), World Health Organization, Geneva 112
38. Barrett-Connor E., and Bush T.L. Estrogen and coronary heart disease in women. JAMA 265 (1991) 1861-1867
39. Seiler C., Hess O.M., Buechi M., Suter T.M., and Krayenbuehl H.P. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 88 (1993) 2139-2148
40. Chen L.Y., and Mehta J.L. Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric-oxide synthase activity in platelets. Life Sci 55 (1994) 1815-1821
41. Zeiher A.M., Drexler H., Saurbier B., and Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 92 (1993) 652-662
42. Casino P.R., Crescence M.K., Quyyumi A.A., Hoeg J.M., and Panza J.A. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88 (1993) 2541-2547
43. Bode-Böger S.M., Böger R.H., Kienke S., Junker W., and Frölich J.C. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219 (1996) 598-603
44. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., and Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332 (1995) 488-493